Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives

Marco Gallo, Pasqualino Malandrino, Giuseppe Fanciulli, Francesca Rota, Antongiulio Faggiano, Annamaria Colao, NIKE Group, Roberto Buzzoni, Jorgelina Coppa, Massimo Milione, Sara Pusceddu

Research output: Contribution to journalReview articlepeer-review

Fingerprint Dive into the research topics of 'Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives'. Together they form a unique fingerprint.

Medicine & Life Sciences